TTUHSC School of Medicine
HomeSchool of MedicineAmarilloResearch

School of Medicine Cancer Research Group

stephen wright

Stephen Wright, MD (Principal Investigator)

Associate Professor and Chief of Oncology, Amarillo VA Medical Center

Adoptive immunotherapy of ovarian and breast cancer: MUC-1 cytotoxic T lymphocytes; adoptive immunotherapy.

Group members:

Zhenyao Wang
Jamie Ambrose
Earl Gilmore

Mark Dobrzanski, PhD

Mark Dobrzanski, PhD

Assistant Professor, Division of Hematology and Oncology

Research interests in tumor immunology and cancer vaccine research with an emphasis on melanoma and breast cancer. He is particularly interested in examining (i) the roles of select tumor-reactive CD8 effector T cell subpopulations in tumor immunity and their potential as therapeutic agents in disseminated malignancy and (ii) studying the mechanisms involved in tumor rejection and evasion.